Promising new drugs for Alzheimer’s disease and stroke, interventions for improving joint health, and a way to predict re-admission and death in patients with coronary heart disease – this week at the Alfred Research Alliance.
This week, two Monash studies have made important advances for joint health, including its connection to heart health.
Alfred Health
Helping raise vital awareness
When Nadine Udorovic’s father, John was diagnosed with brain cancer in 2005, it came completely out of the blue.
Read more
Monash University – Central Clinical School
Monash clinical trials of new drug shows promise for Alzheimer’s disease and dementia
A Monash University-led study has found a promising new treatment for patients with the second-most common form of dementia in people under 60, resulting in a stabilising of escalating behavioural issues, and a reversal of brain shrinkage due to the disease.
Read more
New clot-busting drug may improve treatment for stroke patients
A team of Monash University researchers has demonstrated that an innovative drug that removes blood clots improves the outcomes of acute ischaemic stroke and has a promising safety profile.
Read more
Monash University – School of Public Health and Preventive Medicine
Joining the dots on joint health and heart health
A new study underlines the importance of preventing weight gain versus weight reduction, and the interconnectedness of joint health and heart health.
Read more
New genetic risk assessment for osteoarthritis may reduce joint replacements
A new risk assessment tool validated by researchers at the Monash School of Public Health and Preventive Medicine may help reduce the need for knee and hip replacements among osteoarthritis (OA) patients.
Read more
Baker Heart and Diabetes Institute
Sisters’ plea to find answers to the diabetes pandemic
Mercieca Raimondo and Mary Rizzo have a family tree that has type 2 diabetes on many of its branches, but the sisters are determined to play their part in helping to put a stop to their family’s cycle of disease.
Read more
Benefit of risk-guided strategy to prevent secondary heart events
A cardiovascular event risk score has been shown to be useful in predicting re-admission and death in patients with coronary heart disease after hospital discharge, and to test whether higher-risk patients benefit from more intensive management.
Read more
Fast Five with Dr David Chieng
As a child, Dr David Chieng wanted to choose a career that could make a difference to people’s lives. David, a cardiologist and Baker Heart and Diabetes Institute PhD student in the Clinical Electrophysiology laboratory, is now living his dream, working towards improving outcomes for patients with atrial fibrillation, the most common arrhythmia worldwide.
Read more